Meeting
2015 Gastrointestinal Cancers Symposium
Effects of neoadjuvant therapy on pancreatic cancer stem cells.
Authors
Adam R. Miller
Indiana University, Indianapolis, IN
Adam R. Miller , Whitney H. Horsley , George Sandusky , Melissa Stanley , Bert H. O'Neil , Safi Shahda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 292)
DOI
10.1200/jco.2015.33.3_suppl.292
Abstract #
292
Poster Bd #
B13
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Resection of pancreatic cancer following induction chemotherapy.
First Author: Walid Labib Shaib
Poster
2024 ASCO Annual Meeting
Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer.
First Author: Darren Lee
Poster
2022 ASCO Annual Meeting
Do we need postoperative chemotherapy after preoperative FOLFIRINOX in resected borderline or locally advanced pancreatic cancer? A retrospective analysis.
First Author: Roxane Mari
Poster
2022 ASCO Annual Meeting
Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Updated final results of the randomized phase II AIO-NEONAX trial.
First Author: Thomas Jens Ettrich